Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BG00012 plus methotrexate in adults with rheumatoid arthritis with inadequate response to methotrexate
ACTRN12608000644369Phase 2Not yet recruiting
- Sponsor
- Biogen
- Start
- Dec 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial of dimethyl fumarate in rheumatoid arthritis (RA) (3 arms), sponsored by Biogen. Primary endpoint: ACR20 response. Planned start Dec 2008; status: not yet recruiting.
02
Drugs
dimethyl fumarate
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on ACTRN12608000644369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000644369.